Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Hepatitis B Core Protein Is Post-Translationally Modified through K29-Linked Ubiquitination

H. Langerová, B. Lubyová, A. Zábranský, M. Hubálek, K. Glendová, L. Aillot, J. Hodek, D. Strunin, V. Janovec, I. Hirsch, J. Weber

. 2020 ; 9 (12) : . [pub] 20201126

Language English Country Switzerland

Document type Journal Article, Research Support, Non-U.S. Gov't

Hepatitis B virus (HBV) core protein (HBc) plays many roles in the HBV life cycle, such as regulation of transcription, RNA encapsidation, reverse transcription, and viral release. To accomplish these functions, HBc interacts with many host proteins and undergoes different post-translational modifications (PTMs). One of the most common PTMs is ubiquitination, which was shown to change the function, stability, and intracellular localization of different viral proteins, but the role of HBc ubiquitination in the HBV life cycle remains unknown. Here, we found that HBc protein is post-translationally modified through K29-linked ubiquitination. We performed a series of co-immunoprecipitation experiments with wild-type HBc, lysine to arginine HBc mutants and wild-type ubiquitin, single lysine to arginine ubiquitin mutants, or single ubiquitin-accepting lysine constructs. We observed that HBc protein could be modified by ubiquitination in transfected as well as infected hepatoma cells. In addition, ubiquitination predominantly occurred on HBc lysine 7 and the preferred ubiquitin chain linkage was through ubiquitin-K29. Mass spectrometry (MS) analyses detected ubiquitin protein ligase E3 component N-recognin 5 (UBR5) as a potential E3 ubiquitin ligase involved in K29-linked ubiquitination. These findings emphasize that ubiquitination of HBc may play an important role in HBV life cycle.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019792
003      
CZ-PrNML
005      
20210830101404.0
007      
ta
008      
210728s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/cells9122547 $2 doi
035    __
$a (PubMed)33256078
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Langerová, Hana $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, IOCB Gilead Research Center, 16000 Prague, Czech Republic
245    10
$a Hepatitis B Core Protein Is Post-Translationally Modified through K29-Linked Ubiquitination / $c H. Langerová, B. Lubyová, A. Zábranský, M. Hubálek, K. Glendová, L. Aillot, J. Hodek, D. Strunin, V. Janovec, I. Hirsch, J. Weber
520    9_
$a Hepatitis B virus (HBV) core protein (HBc) plays many roles in the HBV life cycle, such as regulation of transcription, RNA encapsidation, reverse transcription, and viral release. To accomplish these functions, HBc interacts with many host proteins and undergoes different post-translational modifications (PTMs). One of the most common PTMs is ubiquitination, which was shown to change the function, stability, and intracellular localization of different viral proteins, but the role of HBc ubiquitination in the HBV life cycle remains unknown. Here, we found that HBc protein is post-translationally modified through K29-linked ubiquitination. We performed a series of co-immunoprecipitation experiments with wild-type HBc, lysine to arginine HBc mutants and wild-type ubiquitin, single lysine to arginine ubiquitin mutants, or single ubiquitin-accepting lysine constructs. We observed that HBc protein could be modified by ubiquitination in transfected as well as infected hepatoma cells. In addition, ubiquitination predominantly occurred on HBc lysine 7 and the preferred ubiquitin chain linkage was through ubiquitin-K29. Mass spectrometry (MS) analyses detected ubiquitin protein ligase E3 component N-recognin 5 (UBR5) as a potential E3 ubiquitin ligase involved in K29-linked ubiquitination. These findings emphasize that ubiquitination of HBc may play an important role in HBV life cycle.
650    _2
$a arginin $x genetika $7 D001120
650    _2
$a hepatocelulární karcinom $x genetika $7 D006528
650    _2
$a buněčné linie $7 D002460
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a HEK293 buňky $7 D057809
650    _2
$a buňky Hep G2 $7 D056945
650    _2
$a hepatitida B $x genetika $7 D006509
650    _2
$a virus hepatitidy B $x genetika $7 D006515
650    _2
$a lidé $7 D006801
650    _2
$a lysin $x genetika $7 D008239
650    _2
$a posttranslační úpravy proteinů $x genetika $7 D011499
650    _2
$a ubikvitin $x genetika $7 D025801
650    _2
$a ubikvitinligasy $x genetika $7 D044767
650    _2
$a ubikvitinace $x genetika $7 D054875
650    _2
$a virové proteiny $x genetika $7 D014764
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Lubyová, Barbora $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, IOCB Gilead Research Center, 16000 Prague, Czech Republic
700    1_
$a Zábranský, Aleš $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, IOCB Gilead Research Center, 16000 Prague, Czech Republic
700    1_
$a Hubálek, Martin $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, IOCB Gilead Research Center, 16000 Prague, Czech Republic
700    1_
$a Glendová, Kristýna $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, IOCB Gilead Research Center, 16000 Prague, Czech Republic $u Department of Genetics and Microbiology, Faculty of Science, Charles University, BIOCEV, 25250 Vestec, Czech Republic
700    1_
$a Aillot, Ludovic $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, IOCB Gilead Research Center, 16000 Prague, Czech Republic
700    1_
$a Hodek, Jan $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, IOCB Gilead Research Center, 16000 Prague, Czech Republic
700    1_
$a Strunin, Dmytro $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, IOCB Gilead Research Center, 16000 Prague, Czech Republic
700    1_
$a Janovec, Václav $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, IOCB Gilead Research Center, 16000 Prague, Czech Republic $u Department of Genetics and Microbiology, Faculty of Science, Charles University, BIOCEV, 25250 Vestec, Czech Republic
700    1_
$a Hirsch, Ivan $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, IOCB Gilead Research Center, 16000 Prague, Czech Republic $u Department of Genetics and Microbiology, Faculty of Science, Charles University, BIOCEV, 25250 Vestec, Czech Republic $u Institute of Molecular Genetics of the Czech Academy of Sciences, 14220 Prague, Czech Republic
700    1_
$a Weber, Jan $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, IOCB Gilead Research Center, 16000 Prague, Czech Republic
773    0_
$w MED00194911 $t Cells $x 2073-4409 $g Roč. 9, č. 12 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33256078 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830101404 $b ABA008
999    __
$a ok $b bmc $g 1690576 $s 1140238
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 9 $c 12 $e 20201126 $i 2073-4409 $m Cells $n Cells $x MED00194911
LZP    __
$a Pubmed-20210728

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...